News
zambon-02-2024

A common goal, to improve the lives of patients

suede-en

OTC switch approval in Sweden for Virono®50mg

argentine-en

A brighter horizon for Oropharyngeal Candidiasis patients in Argentina

loramyc-mexico-en-2

Loramyc® Marketing autorization granted in mexico !

Happy-new-year-2024

Happy 2024 !

otcswitch

OTC switch approval in Finland for Sitavig® 50mg

VISUEL-MENARINI

Exclusive agreement with the Menarini group and Berlin Chemie

Season's greetings 2023

Season's greetings

posts-VECTANS2022-pierre ATTALI

Vectans Pharma participated in a symposium about new treatments in Oropharyngeal Candidiasis